• Posted 19-Jan-2017

Consultation on the EU Paediatric Regulation

All stakeholders involved in the development, manufacture and/or commercialisation of paediatric medicines, as well as paediatric patient/parent groups, healthcare professionals and academia are invited to contribute to consultation on the experience acquired with the EU Paediatric Regulation.

The purpose of this consultation is to support the European Commission in drafting its second report on the 2006 Paediatric Regulation and to gather stakeholder views and feedback.

Stakeholders are invited to comment on this consultation by 20 February 2017 at the latest.

More information: http://ec.europa.eu/health/human-use/paediatric-medicines/developments/2016_pc_report_2017_en